Eric Carlson, Ph.D., President & CEO. Dr Carlson joined Protein Metrics in January of 2014 as the Chief Business Officer and was chosen to become President & CEO in January of 2017. Dr. Carlson has over 18 years of experience developing and commercializing novel technologies for pharmaceutical R&D labs. Before joining Protein Metrics, Dr. Carlson was a co-founder and senior vice president of Freeslate and spent 12 years at Symyx Technologies. He received his M.S. and Ph.D. degrees in Chemical Engineering from Stanford University in 1994 and 1998, respectively. Dr. Carlson has authored 32 published patents and is the lead author on a chapter on automation for stress testing studies in Pharmaceutical Stress Testing: Predicting Drug Degradation, 2nd Edition (Informa, 2011).
Marshall Bern, Ph.D., Vice President of Research and Co-founder. Dr. Bern has over 30 years of experience in algorithm design and statistical data analysis in areas such as signal and image processing, combinatorial optimization, computational geometry, genomics, proteomics, and glycomics. He has spent many years employed at PARC, a Xerox company. Dr. Bern has a M.A. in applied mathematics and statistics from University of Texas at Austin and a Ph.D. in computer science from UC Berkeley.
Yong Kil, Ph.D., Vice President of Development and Co-founder. Dr. Kil has extensive industrial software engineering experience. His Ph.D. research focused on scientific visualization, image rendering of large data sets, and parallel and out-of-core algorithms. He has five years of experience in proteomics and mass spectrometry, and holds a Ph.D. in computer science from UC Davis.
Gordon Ringold, Ph.D., Outside Director. Dr. Ringold joined Protein Metrics board in mid 2013 and is currently Executive Chairman of Alavita Pharmaceuticals Inc (2005-present). He is a co-founder and Director of Maxygen and Alexza Pharmaceuticals, and Director of privately-held 3V Biosciences. He has over twenty-five years of experience managing the discovery and development of pharmaceuticals and novel, enabling life science technologies. Dr Ringold also has recently served his alma mater, UC Santa Cruz, as Director of Silicon Valley Initiatives reporting directly to the Chancellor. From 2000 to 2005, Dr. Ringold served as Chairman and CEO of SurroMed, Inc., a biotechnology company focused on novel biomarker discovery. From 1995 to 2000, Dr. Ringold was CEO of the Glaxo-Wellcome Group’s Affymax Research Institute, where he managed the development of novel technologies to accelerate the pace of drug discovery. Before serving as CEO, Dr. Ringold was the President and Scientific Director of Affymax where he was instrumental in nurturing the development of the DNA shuffling technology and interacting with key parties to establish Maxygen. Prior to Affymax, he served as Director and Vice President of the Institute for Cancer and Development Biology at Syntex, now a division of Roche (1986-1991). Dr. Ringold received his BS in Biology from University of California, Santa Cruz, and his PhD in Microbiology from University of California, San Francisco in the laboratory of Dr. Harold Varmus. He was on the faculty of the Department of Pharmacology at the Stanford University School of Medicine from 1978-1987.
Andrew Yang, Ph.D., Outside Director. Dr. Yang joined the Board of Protein Metrics at the beginning of 2014. Since 2011 he has been on the management team of ANSYS when the company acquired Apache Design Solutions, which Yang founded in 2001. Prior to his work at ANSYS, Yang was an active entrepreneur and EDA investor, founding Anagram and serving as chairman and CTO until its acquisition by Avant! Corporation. Yang also served as lead investor in several successful technology companies including CADMOS Design Technology (now Cadence Design Systems), InnoLogic Systems (now Synopsys), Ultima Interconnect Technology (now Cadence Design Systems), and Mojave (now Magma Design Automation). A former tenured professor at the University of Washington, Yang holds a B.S. in electrical engineering from the University of California, Berkeley and M.S. and Ph.D. degrees from the University of Illinois. Dr. Yang received the Distinguished Alumni Award from the University of Illinois in 2011.